https://www.selleckchem.com/pr....oducts/epacadostat-i
The improvement in treatment of pediatric acute lymphatic leukemia (ALL) has introduced new challenges for pediatric oncology care in understanding and handling long-term treatment-related complications later in adult life. The aim of this study was to describe health related quality of life (HRQoL) and the relation to buffering factors among young adult (YA) pediatric ALL survivors and their siblings. This cross-sectional study was performed among 227 adults, treated for pediatric ALL in Sweden between 1985 and 1997 and
Like
Comment
Share
